Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): One‐year safety and effectiveness analyses

BACKGROUND: The safety and effectiveness of edoxaban in real‐world clinical settings have not yet been elucidated thoroughly among Japanese patients with nonvalvular atrial fibrillation (NVAF). We report the one‐year interim results of ETNA‐AF‐Japan (Edoxaban Treatment in routiNe clinical prActice i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Takeshi, Koretsune, Yukihiro, Nagao, Tomoko, Shiosakai, Kazuhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279995/
https://www.ncbi.nlm.nih.gov/pubmed/32528563
http://dx.doi.org/10.1002/joa3.12332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279995/
https://www.ncbi.nlm.nih.gov/pubmed/32528563
http://dx.doi.org/10.1002/joa3.12332

Ejemplares similares